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Abstract 
Introduction: Hepatitis C virus is an RNA virus 
that is affecting almost 170 million people 
worldwide. Hepatitis C is also associated with 
increased incidence of chronic liver diseases, liver 
cirrhosis and hepatocellular carcinoma. Therefore 
serum levels of ALT are considered to be the more 
specific indicator of hepatocellular damage than 
serum levels of AST. Serum ALT levels vary 
according to age and gender. 
Materials And Methods:This is a descriptive 
cross sectional study that was conducted from 
September 2016 to April 2017 at Centre of Liver 
Diseases of Holy Family Hospital, Rawalpindi after 
approval from Institutional Research Forum of 
Rawalpindi Medical University. Consecutive non-
probability sampling technique was used. 
The findings of serum ALT levels were classified 
into 5 groups: <40u/l, 41-60u/l, 61-80u/l,81-100u/l and 
>100u/l. Normal value of serum ALT levels was 
<40u/l. 
Patients were divided into 5 age groups: 10-25 years, 
25-40 years, 40-55 years, 55-70 years and >70 years. 
The data was analyzed using SPSS v22. Frequency 
and Percentages were calculated for gender, age and 
serum ALT levels. 
Results:405 (198 male and 207 female) patients were 
included in this research. Mean ALT levels in male 
patients were 89.5u/l while in female patients were 
70.4u/l. The difference between their mean values 
was significant (P=0.016). Serum ALT levels of 24.2% 
(98) patients were within normal range (<40u/l) 
while they were deranged (>40u/l) in 75.8% (307) 
patients. Serum ALT levels were higher in female 
patients in all age groups  
Conclusion: It was concluded that serum ALT 
levels vary significantly with age and gender. 
Elevation of serum ALT is seen more frequently in 
male than in female patients although mean ALT 
levels are higher in female patients in all age groups 
than in male patients. 
 
Introduction 
Liver plays an important role in the metabolism of 
carbohydrates, lipids and proteins. It also detoxifies 
waste products of metabolism by various processes 
like amino acid deamination. It is responsible for 
synthesis and secretion of bile. It also synthesizes 
lipoproteins, plasma proteins and clotting factors.1 It 
also synthesizes many enzymes that catalyze various 
biochemical reactions of the body like Alanine 
Transaminase (ALT), Aspartate Transaminase (AST), 
Gamma Glutamyl Transferase (GGT), Lactate 
Dehydrogenase (LDH) etc.2 Hepatitis C virus is an 
RNA virus that is affecting almost 170 million people 
worldwide.2 It has 6 different genotypes. Genotype 3a 
is the most prevalent genotype of HCV in Pakistan.3, 4 
Hepatitis C is also associated with increased incidence 
of chronic liver diseases, liver cirrhosis and 
hepatocellular carcinoma.5, 6 It has been established 
that serum levels of ALT and AST are deranged in 
chronic liver diseases like hepatitis. ALT is 3000 times 
while AST is 7000 times more active in liver than in 
serum. ALT is exclusively cytoplasmic while AST is 
present in both mitochondria as well as cytoplasm. 
The half-life of ALT is 47±10 hours.7-9 ALT and AST 
are synthesized throughout the body. AST is found 
primarily in skeletal muscles, heart, liver and kidney 
while ALT is found primarily in liver and kidney. It is 
present in lesser amounts in skeletal muscles and 
heart.10-12 Activity of ALT is higher than the activity of 
AST in chronic liver diseases except for Alcoholic 
Hepatitis and Reye Syndrome. That is because most of 
the liver diseases decrease hepatocyte activity of both 
mitochondrial as well as cytoplasmic AST, but alcohol 
decreases cytoplasmic activity of AST only and 
induces release of AST from mitochondria.13-16 
Therefore serum levels of ALT are considered to be the 
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more specific indicator of hepatocellular damage than 
serum levels of AST.17 Serum ALT levels vary 
according to age and sex.17-18 Considering the 
significance of serum ALT levels and variation with 
gender, the objective of this study was to compare the 
mean serum levels of ALT in patients of hepatitis C in 
accordance with gender. 
 
Materials & Methods 
This is a descriptive cross sectional study that was 
conducted from September 2016 to April 2017 at 
Centre of Liver Diseases of Holy Family Hospital, 
Rawalpindi after approval from Institutional Research 
Forum of Rawalpindi Medical University. Consecutive 
non-probability sampling technique was used. 
From the patients presenting to Centre of Liver 
Diseases during the period of 8 months, 405 patients 
with diagnosis of Hepatitis C confirmed by ELISA 
were included in this study. Patients receiving 
hepatotoxic drugs, less than 10 or more than 80 years 
of age, with metabolic liver diseases, with acute 
hepatitis (hepatitis A and E) or patients with hepatitis 
B or D were excluded. 
Serum ALT levels were performed within 24 hours of 
the diagnosis of Hepatitis C by drawing 5ml blood 
from antecubital vein under strict aseptic conditions. 
Using Rotofix-32 machine, Blood was centrifuged for 
3-5 minutes while Beckman Coulter AU-480 
automation machine was used to determine serum 
ALT levels 
The findings of serum ALT levels were classified into 5 
groups: <40u/l, 41-60u/l, 61-80u/l,81-100u/l and 
>100u/l. Normal value of serum ALT levels was 
<40u/l. 
Patients were divided into 5 age groups: 10-25 years, 
25-40 years, 40-55 years, 55-70 years and >70 years. 
The data was analyzed using SPSS v22. Frequency and 
Percentages were calculated for gender, age, genotype 
of virus and serum ALT levels. Kolmogorov Smirnov 
& Shapiro Wilk tests were applied to check normality 
of distribution of data for serum ALT levels-Gender 
and Serum ALT-Various age groups. Independent 
Student’s “t” test was applied to compare mean serum 
ALT levels of male with female patients. 
 
Results 
405 (198 male and 207 female) patients were included 
in this research. Mean ALT levels in male patients 
were 89.485u/l while in female patients were 
70.974u/l. The difference between their mean values 
was statistically significant. (P=0.016) (P<0.05) (Table I) 
(Graph I) 
TABLE I: This table provides mean serum ALT levels 
in male and female Hepatitis C Patients 
GENDER MEAN SERUM 
ALT LEVELS 
Independent students 
“t” test 
MALE  89.48 t=2.430, df= 403, 
P=0.016 FEMALE 70.37 
 
(Table II): Gender wise distribution of patients and 
their serum ALT levels have been classified into 
various ranges 
Serum 
ALT 
Levels 
Range 
Freq
uen
cy 
%age GENDER 
MALE FEMALE 
Frequen
cy 
%age Frequ
ency 
%AGE 
<40 u/l 98 24.2 % 41 20.7 % 57 27.5 % 
41-60 
u/l 
90 22.2 % 36 18.2 % 54 26.1 % 
61-80 
u/l 
72 17.8 % 40 20.2 % 32 15.5 % 
81-100 
u/l 
57 14.1 % 25 12.6 % 32 15.5 % 
>100 u/l 88 21.7 % 41 28.3 % 32 15.5 % 
 
(Table III): Age wise distribution of patients and their 
mean serum ALT levels 
AGE 
GROUPS 
NO. OF 
PATIENTS 
%OF 
PATIENTS 
MEAN 
SERUM ALT 
LEVELS 
10-25 24 5.9 % 110.21 
26-40 99 24.4 % 87.54 
41-55 199 49.1 % 75.53 
56-70 81 20.0 % 72.30 
>70 2 0.5 % 44.50 
TOTAL 405 100 %  
The tables explains the relation between mean serum 
ALT levels and various age groups of the patients. The 
frequency of patients has also been stated 
 
 
(GRAPH I): Relation between Gender-Age and Mean 
serum ALT levels. 
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This graph explains that mean levels of serum ALT are 
higher in all age groups in female patients as 
compared to male patients. 
 
Serum ALT levels of 24.2% (98) patients were within 
normal range (<40u/l) while they were deranged 
(>40u/l) in 75.8% (307) patients. 
It was observed that Serum ALT levels of most of the 
female (27.5%) patients lied within normal range 
(<40u/l) while they were severely deranged (>100u/l) 
in most of the male (28.3%) patients. (Table II) 
The data was normally distributed according to 
Kolmogorov Smirnov & Shapiro Wilk tests. 
The mean age of the patients was 46.46 years, 
45.63years in male while 47.25years in female patients. 
Patients were also classified according to their age 
groups. 49.1% (199) patients belonged to age group of 
41-55 years. The maximum values of serum ALT levels 
were observed in young patients 10-25 years age. 
(Table III) 
Serum ALT levels were higher in female patients in all 
age groups. (Graph I) 
 
Discussion 
Elevation in serum levels of aminotransferases is 
considered to be an indicator of hepatocellular damage 
owing to their hepatic concentration. However ALT is 
considered to be more specific for liver damage than 
AST.19 Serum ALT levels increase significantly with 
periportal bridging necrosis. It has been noted that 
there is a linear relationship between the degree of 
elevation of serum ALT and extent of liver injury as 
predicted by HAI score.20 
Growing evidence has suggested that up to 25% of 
patients with chronic hepatitis C virus infection have 
persistently normal aminotransferase levels (10% to 
40%, according to different studies).21  It is also in 
accordance with our study in which serum ALT levels 
of 24.2% of the patients were within normal range.22-24   
Elevation of serum ALT levels in PCR_RNA positive 
HCV patients with normal controls has been 
documented in 85% of the patients.25 The linear 
regression model developed a  relationship between 
RT-PCR tested for HCV RNA viral load and serum 
ALT levels(26) The relation of liver enzymes with viral 
load has also been developed. It was observed that 
levels of ALT and other hepatic enzymes had 
significant association with the stage of liver fibrosis 
and the grade of inflammation.27 It has been concluded 
by previously done studies that both ALT and AST 
can be the useful markers for Chronic Hepatitis C. 
However, the AST might elevate alone, which suggests 
that measuring AST may be useful only when the ALT 
is consistently normal.  AST/ALT ratio ≥1 is highly 
suggestive of liver cirrhosis.28 The relation between 
duration of HCV infection and elevation of ALT levels 
has also been established.29 
In a study conducted in Peshawar, it was observed 
that Majority of the patients of chronic hepatitis were 
female, in age group 21-40 years, and having ALT in 
range of 41-80 U/L.30 These observations are in 
accordance with our study as 40% patients had serum 
ALT levels in the range 41-80 U/L and 74% patients 
belonged to age group 26-55 years which is also in 
accordance with the study of Farooqi et al. 
Testing for HCV antibodies and hepatitis B surface 
antigens is advisable for all patients presenting with a 
mild increase in aminotransferase levels and at high 
risk of developing hepatitis.31-34 It has been stated that 
in patients with an ALT level between 50-100 IU/l, 
HCV prevalence is tenfold the prevalence in general 
population, whereas HBV prevalence is not affected. 
Therefore, diagnostic follow-up for HCV is suggested 
in these patients.21 
Ruhl et al conducted a study to determine upper limits 
of normal levels of ALT in the population of United 
States. It was observed that for HCV RNA positive 
men, median ALT was 53 while for women it was 36 
as compared to 75 and 57 respectively in our study. 
Since study conducted by Ruhl et al is a survey 
conducted for screening purposes and targeted 
general population, therefore the values are 
comparatively lower as compared to this study.35   
It has been stated by some studies that the degree of 
aminotransferase alteration is a poor guide to the 
severity of the disease in patients with established 
chronic viral hepatitis. However in cases with an 
AST/ALT ratio greater than 1, there is significant 
chance of progression to liver cirrhosis. An AST/ALT 
ratio greater than 1 can be found in 4% of patients with 
chronic hepatitis C infection and in 79% of patients 
who also have liver cirrhosis.36 
Puoti at el concluded that patients with HCV RNA 
positive patients with normal ALT levels were more 
likely to be female which is in accordance with our 
study since it was observed that 58% of the HCV RNA 
positive patients with normal ALT levels were 
female.37   
 
Conclusion 
It was concluded that serum ALT levels vary 
significantly with gender as mean serum ALT levels in 
female are higher than mean serum ALT levels of 
male. 
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